找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Antibody Methods and Protocols; Gabriele Proetzel,Hilmar Ebersbach Book 2012 Springer Science+Business Media, LLC 2012 Antibodies.Antibody

[復(fù)制鏈接]
樓主: 氣泡
41#
發(fā)表于 2025-3-28 14:46:28 | 只看該作者
The Application of Transgenic Mice for Therapeutic Antibody Discovery,ion (FDA). Since then, a further seven such antibodies have been approved. In this chapter, we discuss how transgenic mice technologies can provide a powerful platform for creating human therapeutic antibodies.
42#
發(fā)表于 2025-3-28 22:15:48 | 只看該作者
Production of Human or Humanized Antibodies in Mice,fined immunization protocols. Such an approach allows optimal in vivo affinity maturation of the humoral response. In addition, high-affinity antibodies arising in this context can readily be further characterized and produced as monoclonals after immortalizing and selecting specific antibody-produc
43#
發(fā)表于 2025-3-29 02:12:50 | 只看該作者
44#
發(fā)表于 2025-3-29 04:41:34 | 只看該作者
45#
發(fā)表于 2025-3-29 09:32:35 | 只看該作者
46#
發(fā)表于 2025-3-29 14:28:18 | 只看該作者
47#
發(fā)表于 2025-3-29 17:59:18 | 只看該作者
Cloning, Expression, and Purification of Monoclonal Antibodies in scFv-Fc Format,v-Fc expression cassette into a mammalian expression vector followed by transient transfection of mammalian cells and purification by protein A affinity chromatography. The protocol is intended for applications in basic and preclinical research that require rapid access to milligram amounts of prote
48#
發(fā)表于 2025-3-29 19:46:29 | 只看該作者
PEGylation of Antibody Fragments for Half-Life Extension,antages, including higher mobility and tissue penetration, ability to bind antigen monovalently and lack of fragment crystallizable (Fc) region-mediated functions such as antibody-dependent cell mediated cytotoxicity (ADCC) or complement-dependent cytotoxicity (CDC). The main drawback for the use of
49#
發(fā)表于 2025-3-30 01:02:37 | 只看該作者
50#
發(fā)表于 2025-3-30 06:28:40 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-19 02:42
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
金秀| 伊宁市| 陆良县| 凉城县| 林周县| 荔波县| 尚志市| 曲周县| 中宁县| 长治市| 竹山县| 莱州市| 西宁市| 龙游县| 会同县| 民和| 南城县| 二连浩特市| 大埔区| 抚宁县| 苍山县| 盐边县| 梧州市| 巴南区| 丹阳市| 江北区| 夏河县| 芮城县| 淳安县| 仁寿县| 祁门县| 桂平市| 延川县| 济阳县| 来宾市| 温宿县| 通江县| 西青区| 天镇县| 时尚| 宜兰市|